Literature DB >> 24854163

Wogonoside ameliorates lipopolysaccharide-induced acute lung injury in mice.

Liang Zhang1, Yi Ren, Chengliang Yang, Yue Guo, Xiaojing Zhang, Gang Hou, Xinjin Guo, Nan Sun, Yongyu Liu.   

Abstract

Wogonoside has been reported to have anti-inflammatory properties. In this study, we evaluated the effect of wogonoside on lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice. Male BALB/c mice with ALI, induced by intranasal instillation of LPS, were treated with wogonoside 1 h prior to LPS exposure. Mice treated with LPS alone showed significantly increased TNF-α, IL-6, and IL-1β levels in the bronchoalveolar lavage fluid (BALF). When pretreated with wogonoside, the TNF-α, IL-6, and IL-1β levels were significantly decreased. Meanwhile, wogonoside significantly inhibited LPS-induced increases in the macrophage and neutrophil infiltration of lung tissues and markedly attenuated myeloperoxidase activity. Furthermore, wogonoside inhibited the TLR4 expression and the phosphorylation of NF-κB p65, and IκB induced by LPS. In conclusion, our results indicate that wogonoside exhibits a protective effect on LPS-induced ALI via suppression of TLR4-mediated NF-κB signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24854163     DOI: 10.1007/s10753-014-9932-z

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  27 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Cytokine-mediated inflammation in acute lung injury.

Authors:  Richard B Goodman; Jérôme Pugin; Janet S Lee; Michael A Matthay
Journal:  Cytokine Growth Factor Rev       Date:  2003-12       Impact factor: 7.638

3.  Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling.

Authors:  Jonathan C Kagan; Ruslan Medzhitov
Journal:  Cell       Date:  2006-06-02       Impact factor: 41.582

4.  Assessing pulmonary permeability by transpulmonary thermodilution allows differentiation of hydrostatic pulmonary edema from ALI/ARDS.

Authors:  Xavier Monnet; Nadia Anguel; David Osman; Olfa Hamzaoui; Christian Richard; Jean-Louis Teboul
Journal:  Intensive Care Med       Date:  2007-01-13       Impact factor: 17.440

5.  Wogonoside displays anti-inflammatory effects through modulating inflammatory mediator expression using RAW264.7 cells.

Authors:  Yao-Zhi Yang; You-Zhi Tang; Ya-Hong Liu
Journal:  J Ethnopharmacol       Date:  2013-04-21       Impact factor: 4.360

6.  Wogonoside inhibits lipopolysaccharide-induced angiogenesis in vitro and in vivo via toll-like receptor 4 signal transduction.

Authors:  Yan Chen; Na Lu; Yun Ling; Ying Gao; Ling Wang; Yu Sun; Qi Qi; Feng Feng; Wenyuan Liu; Wei Liu; Qidong You; Qinglong Guo
Journal:  Toxicology       Date:  2009-01-20       Impact factor: 4.221

7.  Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections.

Authors:  Jae Hyang Lim; Brigid Stirling; Jonathan Derry; Tomoaki Koga; Hirofumi Jono; Chang-Hoon Woo; Haodong Xu; Patricia Bourne; Un-Hwan Ha; Hajime Ishinaga; Haidong Xu; Ali Andalibi; Xin-Hua Feng; Hongguang Zhu; Yuxian Huang; Wenhong Zhang; Xinhua Weng; Chen Yan; Zhinan Yin; David E Briles; Roger J Davis; Richard A Flavell; Jian-Dong Li
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

8.  Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung.

Authors:  Ida A J Giebelen; David J van Westerloo; Gregory J LaRosa; Alex F de Vos; Tom van der Poll
Journal:  Shock       Date:  2007-12       Impact factor: 3.454

9.  Pretreatment of baicalin and wogonoside with glycoside hydrolase: a promising approach to enhance anticancer potential.

Authors:  Chunhao Yu; Zhiyu Zhang; Haijiang Zhang; Zhong Zhen; Tyler Calway; Yunwei Wang; Chun-Su Yuan; Chong-Zhi Wang
Journal:  Oncol Rep       Date:  2013-09-09       Impact factor: 3.906

10.  Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury.

Authors:  Yumiko Imai; Keiji Kuba; G Greg Neely; Rubina Yaghubian-Malhami; Thomas Perkmann; Geert van Loo; Maria Ermolaeva; Ruud Veldhuizen; Y H Connie Leung; Hongliang Wang; Haolin Liu; Yang Sun; Manolis Pasparakis; Manfred Kopf; Christin Mech; Sina Bavari; J S Malik Peiris; Arthur S Slutsky; Shizuo Akira; Malin Hultqvist; Rikard Holmdahl; John Nicholls; Chengyu Jiang; Christoph J Binder; Josef M Penninger
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582

View more
  8 in total

1.  [Wogonoside alleviates high glucose-induced dysfunction of retinal microvascular endothelial cells and diabetic retinopathy in rats by up-regulating SIRT1].

Authors:  X Shao; J Yu; W Ni
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-04-20

2.  Wogonoside alleviates inflammation induced by traumatic spinal cord injury by suppressing NF-κB and NLRP3 inflammasome activation.

Authors:  Yonglin Zhu; Hanzhong Zhu; Zhaojie Wang; Fengguang Gao; Jingsheng Wang; Wenqiang Zhang
Journal:  Exp Ther Med       Date:  2017-08-08       Impact factor: 2.447

3.  Wogonoside Shows Antifibrotic Effects in an Experimental Regression Model of Hepatic Fibrosis.

Authors:  Qichao Wang; Rui Wen; Qinghua Lin; Na Wang; Ping Lu; Xianmin Zhu
Journal:  Dig Dis Sci       Date:  2015-07-01       Impact factor: 3.199

4.  Effects of wogonoside on the inflammatory response and oxidative stress in mice with nonalcoholic fatty liver disease.

Authors:  Guangyu Jiang; Dayin Chen; Wenpeng Li; Chengcheng Liu; Jiguang Liu; Yingxue Guo
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

5.  Protective Effect of Xiao-Xu-Ming Decoction-Mediated Inhibition of ROS/NLRP3 Axis on Lipopolysaccharide-Induced Acute Lung Injury In Vitro and In Vivo.

Authors:  Yijin Xiang; Min Cai; Xiangting Li; Xuxia Bao; Dingfang Cai
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-27       Impact factor: 2.629

6.  Network Pharmacology and Experimental Validation to Explore the Mechanism of Qing-Jin-Hua-Tan-Decoction Against Acute Lung Injury.

Authors:  Shunli Xiao; Lu Liu; Zhengxiao Sun; Xiaoqian Liu; Jing Xu; Zhongyuan Guo; Xiaojie Yin; Fulong Liao; Jun Xu; Yun You; Tiejun Zhang
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

7.  Wogonoside inhibits IL-1β induced catabolism and hypertrophy in mouse chondrocyte and ameliorates murine osteoarthritis.

Authors:  Qian Tang; Gang Zheng; Zhenhua Feng; Minji Tong; Jianxiang Xu; Zhiyan Hu; Ping Shang; Yu Chen; Chenggui Wang; Yiting Lou; Deheng Chen; Di Zhang; Majid Nisar; Xiaolei Zhang; Huazi Xu; Haixiao Liu
Journal:  Oncotarget       Date:  2017-06-06

8.  Wogonoside inhibits inflammatory cytokine production in lipopolysaccharide-stimulated macrophage by suppressing the activation of the JNK/c-Jun signaling pathway.

Authors:  Xiu Yu; Dandan Chen; Lingwei Wang; Jie Li; Khalid Khan; Haihui Chen; Yutian Liang; Huanmin Luo; Chen Qiu
Journal:  Ann Transl Med       Date:  2020-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.